New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease
23/06/2025 – AB Science today announced that a new study from an independent research team based in China presents new evidences showing that masitinib offers a promising new approach to treating Alzheimer’s disease